M-14007 Carcinoembryonic Antigen (CEA) Quantitative Test Kit

Clinical Significance: Elevated CEA levels are commonly seen in colorectal cancer, pancreatic cancer, gastric cancer, breast cancer, and medullary thyroid carcinoma. While CEA is not a specific marker for malignant tumors, it has auxiliary diagnostic value. Additionally, serum CEA levels correlate with the staging of colorectal cancer, with higher concentrations found in more advanced stages. In 7% of healthy adults, serum CEA concentration is below 2.5 μg/L. Elevated CEA levels are observed in 45-80% of primary colorectal cancer patients. Apart from primary colorectal cancer, high positivity rates for CEA are also found in pancreatic cancer, cholangiocarcinoma, gastric cancer, esophageal cancer, adenocarcinoma, lung cancer, breast cancer, and urinary system tumors, generally ranging from 50-70%. CEA serves as an auxiliary diagnostic indicator for gastrointestinal tumors.
[Reference Value] ≤5.9 μg/L
Product Specifications: 20 tests per box
Product Shelf Life: Sealed in an aluminum foil bag, the product is valid for 18 months. Once opened, the aluminum foil bag should be used within 1 hour.
Product Storage: Store the test cards at 2°C to 30°C.
 
Usage Scenarios:
Hospitals and Oncology Departments: For auxiliary diagnosis and monitoring of various cancers such as colorectal, pancreatic, gastric, breast, and medullary thyroid carcinoma.
Diagnostic Laboratories: For routine testing of serum CEA levels to aid in the diagnosis and staging of gastrointestinal and other cancers.
Cancer Screening Programs: For early detection and monitoring of cancer progression in high-risk populations.
Suitable Countries and Regions:
Developed Countries: United States, Canada, Western Europe (e.g., Germany, France, UK), Japan, Australia, etc., where advanced diagnostic tools are widely used for cancer diagnosis and management.
Emerging Markets: China, India, Southeast Asia, Latin America, Eastern Europe, Middle East, etc., where healthcare systems are improving cancer diagnostic capabilities and expanding access to modern diagnostic tools.
Global Health Programs: International health initiatives focused on enhancing cancer detection and management in low-resource settings.